A prospective, randomized, placebo-controlled study of the dose effect of oral oestradiol on menopausal symptoms, psychological well being, and quality of life in postmenopausal Chinese women

Maturitas

Volumn 44, Issue 3, 2003, Pages 207-214

  Haines, Christopher J ^a   Yim, So Fan ^a   Chung, Tony K H ^a   Lam, Christopher W K ^a   Lau, Edith W C ^a   Ng, Margaret H L ^a   Chin, Robert ^a   Lee, Dominic T S ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Anxiety; Depression; Hormone replacement therapy; Menopause; Quality of life; Vasomotor symptoms

Indexed keywords

ESTRADIOL;

ADRENERGIC SYSTEM; ANXIETY DISORDER; ARTICLE; CHINESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT; MENOPAUSAL SYNDROME; POSTMENOPAUSE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SEXUAL BEHAVIOR; STATISTICAL SIGNIFICANCE; WELLBEING;

EID: 0037470714     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(02)00340-7     Document Type: Article

References (22)

1. Hagstad J., Janson P.O. The epidemiology of climacteric symptoms. Acta Obstet. Gynecol. Scand. Suppl. 134:1986;59-65.
2. Haines C.J., Chung T.H.K., Leung D.H.Y. A prospective study of the frequency of acute menopausal symptoms in Hong Kong Chinese women. Maturitas. 18:1994;175-181.
3. Chung T.K.H., Yip S.K., Lam P., Chang A.M.Z., Haines C.J. A randomized, double-blind, placebo-controlled, crossover study of the effect of oral oestradiol on acute menopausal symptoms. Maturitas. 25:1996;115-123.
4. Gold E.B., Sternfeld B., Kelsey J.L., Brown C., Mouton C., Reame N., Salamone L., Stellato R. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am. J. Epidemiol. 152:2000;463-473.
5. Cagnacci A., Volpe A., Arangino S., Malmusi S., Draetta F.P., Matteo M.L., Maschio E., Vacca A.M., Melis G.B. Depression and anxiety in climacteric women: role of hormone replacement therapy. Menopause. 4:1997;206-211.
6. Bukulmez O., Al A., Gurdal H., Yarali H., Ulug B., Gurgan T. Short-term effects of three continuous hormone replacement therapy regimens on platelet tritiated imipramine binding and mood scores: a prospective randomized trial. Fertil. Steril. 75:2001;737-743.
7. Montgomery J.C., Appleby L., Brincat M., Versi E., Tapp A., Fenwick P.B., Studd J.W. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet. 1:(8528):1987;297-299.
8. Bech P., Munk-Jensen N., Obel E.B., Ulrich L.G., Eiken P., Nielsen S.P. Combined versus sequential hormonal replacement therapy: a double-blind, placebo-controlled study on quality of life-related outcome measures. Psychother. Psychosom. 67:1998;259-265.
9. Soares C.N., Almeida O.P., Joffe H., Cohen L.S. Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial. Arch. Gen. Psychiatry. 58:2001;529-534.
10. Pearce J., Hawton K., Blake F., Barlow D., Rees M., Fagg J., Keenan J. Psychological effects of continuation versus discontinuation of hormone replacement therapy by estrogen implants: a placebo-controlled study. J. Psychosom. Res. 42:1997;177-186.
11. Blumel J.E., Castelo-Branco C., Binfa L., Gramegna G., Tacla X., Aracena B., Cumsille M.A., Sanjuan A. Quality of life after menopause: a population study. Maturitas. 34:2000;17-23.
12. Hall G., Pripp U., Schenck-Gustafsson K., Landgren B.-M. Longterm effects of hormone replacement therapy on symptoms of angina pectoris, quality of life and compliance in women with coronary artery disease. Maturitas. 28:1997;235-242.
13. Skarsgard C., Berg G., Ekblad S., Wiklund I., Hammar M.L. Effects of estrogen therapy on well-being in postmenopausal women without vasomotor symptoms. Maturitas. 36:2000;123-130.
14. The World Health Organization Quality of Life Assessment: development and general psychometric properties. Soc. Sci. Med. 46:1998;1569-1585.
15. Study protocol for the World Health Organization project to develop a quality of life assessment instrument (WHOQOL). Qual. Life Res. 2:1993;153-159.
16. Leung KF, Chu MML, Lau JTF. Cultural relevancy of WHOQOL structure in Hong Kong Chinese. Paper presentation in the 1997 Quality of Life Symposium, Hong Kong, 1997.
17. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67:1983;361-370.
18. Leung C.M., Wing Y.K., Kwong P.K., Lo A., Shum K. Validation of the Chinese-Cantonese version of the hospital anxiety and depression scale and comparison with the Hamilton Rating Scale of Depression. Acta Psychiatr. Scand. 100:1999;456-461.
19. Roach V.J., Cheung T.F., Chung T.K.H., Hjelm N.M., Waring M.A., Loong E.P.L., Haines C.J. Phytoestrogens: dietary intake and excretion in postmenopausal Chinese women. Climacteric. 1:1998;290-295.
20. Leung C.M., Ho S., Kan C.S., Hung C.H., Chen C.N. Evaluation of the Chinese version of the Hospital Anxiety and Depression Scale: a cross-cultural perspective. Int. J. Psychosomatics. 40:1993;29-34.
21. Power M., Harper A., Bullinger M. The World Health Organization WHOQOL-100: tests of the universality of quality of life in 15 different cultural groups worldwide. Health Psychol. 18:(5):1999;495-505.
22. Hlatky M.A., Boothroyd D., Vittinghoff E., Sharp P., Whooley M.A. Heart Estrogen/Progestin Replacement Study (HERS) trial. Quality of life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart Estrogen/Progestin Replacement Study (HERS) trial. J. Am. Med. Assoc. 287:2002;591-597.